Podocin Promoter, Reverse Tetracycline Transactivator Mice for Studying Podocyte Injury
This technology includes mice which are intended to be bred with mice that have the tetracycline-response element promoter driving a gene of interest, for the study of kidney diseases. When the dual transgenic mice are fed tetracycline or doxycycline, the transgene is activated in glomerular podocytes.